US Dollar vs Yen

登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

登録

RNXT

RenovoRx (RNXT)

RenovoRx Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:RNXT

1 2 3 4 5 6 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/30	21 : 30	Business Wire	RenovoRx CEO Issues Update Letter to Shareholders	NASDAQ:RNXT	RenovoRx Inc
2024/05/21	22 : 00	Business Wire	Publication of Results of Pre-Clinical Studies Support Efficacy and Drug Delivery Mechanism Potential of RenovoRx’s TAMP™ Therapy Platform to Improve Targeted Cancer Drug Treatment Delivery	NASDAQ:RNXT	RenovoRx Inc
2024/05/14	22 : 00	Business Wire	RenovoRx to Participate in Fireside Chat at the A.G.P. Virtual Healthcare Company Showcase on May 21, 2024	NASDAQ:RNXT	RenovoRx Inc
2024/05/13	13 : 15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:RNXT	RenovoRx Inc
2024/05/13	13 : 15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:RNXT	RenovoRx Inc
2024/05/11	06 : 21	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:RNXT	RenovoRx Inc
2024/05/11	05 : 50	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:RNXT	RenovoRx Inc
2024/05/11	05 : 47	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:RNXT	RenovoRx Inc
2024/05/02	22 : 00	Business Wire	RenovoRx CEO Shaun R. Bagai to Present at the Aegis Capital Virtual Conference on May 9, 2024	NASDAQ:RNXT	RenovoRx Inc
2024/04/18	21 : 30	Business Wire	RenovoRx Regains Compliance with Nasdaq Stockholders’ Equity Requirement	NASDAQ:RNXT	RenovoRx Inc
2024/04/16	21 : 30	Business Wire	RenovoRx Highlights Recent Presentation of Clinical Data Abstract at the 2024 Society of Interventional Radiology Annual Scientific Meeting	NASDAQ:RNXT	RenovoRx Inc
2024/04/15	21 : 00	Business Wire	RenovoRx Closes $11.1 Million Private Placement, Providing Cash Runway into 2026	NASDAQ:RNXT	RenovoRx Inc
2024/04/08	21 : 30	Business Wire	RenovoRx Announces $11.1 Million at Market Private Placement	NASDAQ:RNXT	RenovoRx Inc
2024/04/05	21 : 30	Business Wire	RenovoRx to Present at the Canaccord Genuity Horizons in Oncology Virtual Conference on April 15, 2024	NASDAQ:RNXT	RenovoRx Inc
2024/03/12	22 : 00	Business Wire	RenovoRx to Present at the 36th Annual ROTH Conference on March 19, 2024	NASDAQ:RNXT	RenovoRx Inc
2024/03/09	06 : 28	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RNXT	RenovoRx Inc
2024/03/09	06 : 26	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:RNXT	RenovoRx Inc
2024/03/09	06 : 05	Business Wire	RenovoRx Highlights Key Leadership Promotions	NASDAQ:RNXT	RenovoRx Inc
2024/02/13	09 : 46	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RNXT	RenovoRx Inc
2024/02/13	09 : 39	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:RNXT	RenovoRx Inc
2024/02/10	06 : 30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RNXT	RenovoRx Inc
2024/02/10	06 : 15	Edgar (US Regulatory)	Form D - Notice of Exempt Offering of Securities	NASDAQ:RNXT	RenovoRx Inc
2024/02/06	22 : 30	Business Wire	RenovoRx CEO Issues Letter to Shareholders	NASDAQ:RNXT	RenovoRx Inc
2024/01/31	09 : 33	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RNXT	RenovoRx Inc
2024/01/31	08 : 57	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RNXT	RenovoRx Inc
2024/01/31	08 : 32	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RNXT	RenovoRx Inc
2024/01/31	08 : 30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RNXT	RenovoRx Inc
2024/01/29	23 : 06	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RNXT	RenovoRx Inc
2024/01/29	22 : 30	Business Wire	RenovoRx Closes $6.1 Million Private Placement	NASDAQ:RNXT	RenovoRx Inc
2024/01/24	11 : 50	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RNXT	RenovoRx Inc

Showing the most relevant articles for your search:NASDAQ:RNXT

1 2 3 4 5 6 次へ >>

Haymaker Acquisition Cor...

Investec Bnk 26

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約